NYSE · MMS
Industrials · Specialty Business Services
$63.72
Up+$0.88 (+1.40%)
Updated Nov 1, 2026, 4:27 AM
SID Score
5.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MMS
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
MMS closed at $63.72 after 20 trading sessions, up 17.11% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $63.66 | $64.43 | $62.975 | $63.72 | 393.87K |
| Oct 29, 2026 | $63.01 | $63.165 | $62.16 | $62.84 | 401.07K |
| Oct 28, 2026 | $62.81 | $62.88 | $61.09 | $61.81 | 450.99K |
| Oct 27, 2026 | $63.08 | $63.8753 | $62.18 | $62.47 | 376.99K |
| Oct 26, 2026 | $62.84 | $64.05 | $62.77 | $63.50 | 516.65K |
| Oct 23, 2026 | $63.03 | $63.86 | $62.24 | $63.02 | 487.56K |
| Oct 22, 2026 | $62.82 | $64.02 | $62.62 | $63.38 | 680.78K |
| Oct 21, 2026 | $60.96 | $62.67 | $60.96 | $62.07 | 622.39K |
| Oct 20, 2026 | $62.15 | $63.11 | $60.27 | $61.09 | 637.51K |
| Oct 19, 2026 | $60.86 | $62.1499 | $60.67 | $61.33 | 686.25K |
| Oct 16, 2026 | $60.73 | $61.69 | $60.26 | $61.47 | 799.64K |
| Oct 15, 2026 | $58.99 | $60.55 | $58.675 | $60.24 | 569.57K |
| Oct 14, 2026 | $58.10 | $58.6697 | $57.09 | $57.76 | 489.81K |
| Oct 13, 2026 | $59.01 | $59.99 | $57.935 | $58.08 | 714.38K |
| Oct 12, 2026 | $58.29 | $59.91 | $58.29 | $58.87 | 714.91K |
| Oct 9, 2026 | $58.29 | $60.19 | $58.29 | $59.39 | 764.86K |
| Oct 8, 2026 | $55.81 | $58.88 | $55.725 | $58.77 | 1.12M |
| Oct 7, 2026 | $54.69 | $56.04 | $54.04 | $55.65 | 869.47K |
| Oct 6, 2026 | $54.55 | $54.92 | $53.80 | $54.68 | 666.15K |
| Oct 5, 2026 | $52.55 | $54.45 | $52.45 | $54.41 | 731.51K |
The latest Smart Investors Daily articles mentioning MMS.
Company
Market Activity
Research & News
MMS research
Company profile and research snapshot.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 2, 2025 | Raymond James | Outperform | — |
| Jan 3, 2024 | Raymond James | Market Perform | — |
| Aug 18, 2023 | Stifel | Buy | — |
| Feb 9, 2023 | Raymond James | Outperform | — |
| May 6, 2022 | Raymond James | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 24, 2026
Looking back on government & technical consulting stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Maximus (NYSE:MMS) and its peers.
ChartMill · Oct 22, 2026
MAXIMUS (MMS) stands out on the Decent Value screen, combining a cheap valuation with solid profitability, financial health, and adequate growth.
Yahoo · Oct 21, 2026
Maximus (NYSE:MMS) said it has agreed to acquire privately held Agile Defense for $660 million, with a potential future earn-out of up to $50 million, as the government-services company seeks to expand its presence in defense, national security and technology-intensive federal missions. The transac
SeekingAlpha · Oct 20, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MMS.
